Dysregulated expression of CD69 and IL-2 receptor α and β chains on CD8+ T lymphocytes in flaky skin mice

被引:5
|
作者
Abernethy, NJ
Hagan, C
Tan, PL
Watson, JD
机构
[1] Genesis Res & Dev Corp Ltd, Auckland, New Zealand
[2] Christchurch Sch Med, Dept Haematol, Christchurch, New Zealand
来源
IMMUNOLOGY AND CELL BIOLOGY | 2000年 / 78卷 / 06期
关键词
CD122; CD25; CD69; interleukin-2; receptor; lymphadenopathy; psoriasis; T-cell activation;
D O I
10.1046/j.1440-1711.2000.00945.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T-cell activation is considered to be an important element in the pathogenesis of psoriasis, a human skin disease characterized by keratinocyte hyperproliferation, altered keratinocyte differentiation and inflammation of the dermis and epidermis. Mice homozygous for the flaky skin (fsn) mutation develop a skin disorder that has histopathological and biochemical features resembling some forms of psoriasis. It has been reported recently that peripheral lymph nodes (PLN) in fsn/fsn mice exhibit various abnormalities in T-cell development suggestive of dysregulated T- and B-cell activation. In the present study, the expression of the inducible T-cell activation antigens CD69 and IL-2 receptor alpha chain (CD25) on PLN cells from fsn/fsn mice and their phenotypically normal littermates is examined. Expression of CD69 was significantly increased on PLN cells in fsn/fsn mice (mean +/- SD, 49.9 +/- 14.7% of cells) compared with control mice (14.6 +/- 4.2%). Analysis of CD4(+) and CD8(+) T cell subsets revealed that expression of CD69 in fsn/fsn PLN was significantly biased toward CD8(+) cells. Although expression of CD25 was preferentially associated with CD4(+) rather than CD8(+) cells in both fsn/fsn and control PLN, with most CD4(+)CD25(+) cells being CD25(hi), the proportion of CD4(+) cells expressing CD25 was higher in fsn/fsn than control PLN. In contrast, CD25 was expressed by 2-3 % of CD8(+) PLN cells in both fsn/fsn and control mice and CD25(hi) cells accounted for < 1 % of CD8(+) cells in fsn/fsn PLN. The paucity of CD25 on CD8(+) cells in fsn/fsn PLN did not appear to be due to a defect in the ability of these cells to upregulate CD25, because T cell receptor stimulation in vitro induced high expression of CD25 on both CD4(+) and CD8(+) cells. A striking and consistent finding was that most CD8(+) cells in fsn/fsn PLN expressed high levels of IL-2R beta chain (CD122). In contrast, CD122 was expressed at low levels on CD8(+) cells in control mice. Analysis of PLN cells from newborn fsn/fsn mice revealed that the high expression of CD122 on CD8(+) cells was established by 2 weeks of age, prior to the appearance of clinical skin disease. These data indicate that large numbers of T cells in fsn/fsn mice are activated and reinforce the view that fsn is an important regulator of lymphocyte development and function. The relationship between T-cell activation and flaky skin disease in these mice remains to be established.
引用
收藏
页码:596 / 602
页数:7
相关论文
共 50 条
  • [21] SIGNALING IN LYMPHOCYTES-T - A POSSIBLE ACCESSORY PATHWAY INITIATED AT THE CD69 RECEPTOR
    TESTI, R
    CIFONE, MG
    DAMBROSIO, D
    TROTTA, R
    TORELLI, G
    DEMARIA, R
    FRATI, L
    SANTONI, A
    JOURNAL OF IMMUNOLOGICAL RESEARCH, 1992, 4 (03): : 111 - 117
  • [22] Apoptotic cells actively inhibit the expression of CD69 on con A activated T lymphocytes
    Sun, E
    Zhang, L
    Zeng, Y
    Ge, Q
    Zhao, M
    Gao, W
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (03) : 231 - 236
  • [23] IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells
    Yang, YF
    Tomura, M
    Iwasaki, M
    Mukai, T
    Gao, P
    Ono, S
    Zou, JP
    Shearer, GM
    Fujiwara, H
    Hamaoka, T
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (02) : 116 - 125
  • [24] IL-12 as Well as IL-2 Upregulates CCR5 Expression on T Cell Receptor-Triggered Human CD4+ and CD8+ T Cells
    Yi-Fu Yang
    Michio Tomura
    Masayuki Iwasaki
    Takao Mukai
    Ping Gao
    Shiro Ono
    Jian-Ping Zou
    Gene M. Shearer
    Hiromi Fujiwara
    Toshiyuki Hamaoka
    Journal of Clinical Immunology, 2001, 21 : 116 - 125
  • [25] Expression of activation inducer molecule (CD69) on CD3+CD8+ T lymphocytes in children with atopic dermatitis correlates with SCORAD but not with the age of patients
    Chernyshov, P. V.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (04) : 462 - 463
  • [26] The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells
    Redeker, Anke
    Welten, Suzanne P. M.
    Baert, Miranda R. M.
    Vloemans, Sandra A.
    Tiemessen, Machteld M.
    Staal, Frank J. T.
    Arens, Ramon
    JOURNAL OF IMMUNOLOGY, 2015, 195 (10): : 4792 - 4801
  • [27] An engineered IL-2 partial agonist promotes CD8+ T cell stemness
    Mo, Fei
    Yu, Zhiya
    Li, Peng
    Oh, Jangsuk
    Spolski, Rosanne
    Zhao, Liang
    Glassman, Caleb R.
    Yamamoto, Tori N.
    Chen, Yun
    Golebiowski, Filip M.
    Hermans, Dalton
    Majri-Morrison, Sonia
    Picton, Lora K.
    Liao, Wei
    Ren, Min
    Zhuang, Xiaoxuan
    Mitra, Suman
    Lin, Jian-Xin
    Gattinoni, Luca
    Powell, Jonathan D.
    Restifo, Nicholas P.
    Garcia, K. Christopher
    Leonard, Warren J.
    NATURE, 2021, 597 (7877) : 544 - +
  • [28] An engineered IL-2 partial agonist promotes CD8+ T cell stemness
    Fei Mo
    Zhiya Yu
    Peng Li
    Jangsuk Oh
    Rosanne Spolski
    Liang Zhao
    Caleb R. Glassman
    Tori N. Yamamoto
    Yun Chen
    Filip M. Golebiowski
    Dalton Hermans
    Sonia Majri-Morrison
    Lora K. Picton
    Wei Liao
    Min Ren
    Xiaoxuan Zhuang
    Suman Mitra
    Jian-Xin Lin
    Luca Gattinoni
    Jonathan D. Powell
    Nicholas P. Restifo
    K. Christopher Garcia
    Warren J. Leonard
    Nature, 2021, 597 : 544 - 548
  • [29] The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells
    Dai, ZH
    Konieczny, BT
    Lakkis, FG
    JOURNAL OF IMMUNOLOGY, 2000, 165 (06): : 3031 - 3036
  • [30] IL-2 complex rescues CD8+ T cell tolerance for cancer immunotherapy
    Swier, Lauryn
    Berrien, Melissa
    Teague, Ryan
    JOURNAL OF IMMUNOLOGY, 2015, 194